glp 1 mounjaro for weight loss HOW IVE LOST 18LB IN 8 WEEKS on GLP1 medication Mounjaro (tirzepatide) - Diabetes &

* Additional details on other secondary outcomes other than the change in body weight can be found at as NCT03954834 (SURPASS-1), NCT03987919 (SURPASS-2), NCT03882970 (SURPASS-3), NCT03730662 (SURPASS-4), NCT04039503 (SURPASS-5), NCT04537923 (SURPASS-6), NCT04255433 (SURPASS-CVOT), NCT03861052(SURPASS J-mono), NCT04093752 (SURPASS-AP-Combo), and NCT04184622 (SURMOUNT-1)

GLP-1 medications may cause: Nausea Vomiting Constipation Diarrhea Other gastrointestinal symptoms Our physicians carefully monitor treatment and adjust dosing to minimize side effects

10.1016/j.expneurol.2018.01.004 179 KimB

At 8 weeks of age, both experimental groups displayed similar microbial diversity and did not exhibit any significant grouping based on their microbiome

Innovative Formulations: We leverage the latest scientific research to create formulations that offer maximum benefits, ensuring you receive the best that science and nature have to offer